Skip to main content

Table 1 Bacterial strains, plasmids and oligonucleodide primers used in this study.

From: Expression of an endotoxin-free S-layer/allergen fusion protein in gram-positive Bacillus subtilis 1012 for the potential application as vaccines for immunotherapy of atopic allergy

Description

Contents

Reference/source

Strains

  

E. coli TG1

supE thi-1 Δ(lac-proAB) Δ(mcrB-hsdSM)5(rK- mK-) [F' traD36 proAB lacIqZΔM15

Stratagene

B. subtilis 1012

leuA 8, metB 5, hsrM 1, nonA

CatchMaps BV, MoBiTec

Plasmids

  

pET28a/sbpA/bet v1

Cloning of rsbpA/bet v1

[15]

pHT01

Ampr, Cmr, Pgrac promoter (consisting of groEpromotor, the lacO operator and the gsiBSD sequence, ColE1 ori,, lacI repressor, E. coli/B. subtilis shuttle vector

MoBiTec

pHT43

see pHT01 + amyQ signal sequence

MoBiTec

pHT01/sbpA/bet v 1

Expression of rSbpA/Bet v1 in cytoplasm of B. subtilis 1012

This study

pHT43/sbpA/bet v1

Expression of rSbpA/Bet v1 in cytoplasm of B. subtilis 1012 followed by subsequent secretion into the culture medium

This study

Primers*

  

SbpA/AatII/forward

5'-cgcgacgtc gcgcaagtaaacgactataacaaatc-3'

This study

Bet v1/SmaI/reverse

5'-tcccccggg ttagttgtaggcatcggagtgtg-3'

This study

  1. *Bold nucleotide sequences indicate restriction endonuclease sites.